BlackRock Advisors’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

BlackRock Advisors’s Portfolio FURX Stock Details FURX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-13,030	Closed	-$1.38M	–	3804
2014 Q2	$1.38M	Sell	13,030 -14,350	-52%	-$1.41M	﹤0.01%	1313
2014 Q1	$2.38M	Buy	27,380 +22,570	+469%	+$1.74M	﹤0.01%	1138
2013 Q4	$202K	Buy	4,810 +470	+11%	+$19.3K	﹤0.01%	2649
2013 Q3	$191K	Sell	4,340 -3,666	-46%	-$152K	﹤0.01%	2581
2013 Q2	$273K	Buy	+8,006	New	+$281K	﹤0.01%	2272

BlackRock Advisors's FURX Position: Q3 2014 in Review

BlackRock Advisors sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 13,030 shares — an estimated $1.38M sold.

BlackRock Advisors first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $2.38M in Q1 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

BlackRock Advisors reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
BlackRock Advisors sold 13,030 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $1.38M.
BlackRock Advisors first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
BlackRock Advisors's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $2.38M in Q1 2014.
0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on BlackRock Advisors's 13F filing for Q3 2014, filed 29 Oct 2014.